Pharmaust Limited (AU:PAA) has released an update.
Pharmaust Limited has disclosed the commencement of John Clark’s role as a director on May 9, 2024, along with his initial interests in the company. Clark holds 1,125,000 Performance Rights and 250,000 Unlisted Options expiring January 19, 2026, at $0.175 each. This information, provided under the listing rule 3.19A.1, reflects Clark’s vested stake in the company’s success.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
